Obesity Clinical Trial
Official title:
Pilot Study to Examine the Effects of Weight Gain on Adipose Tissue
This study aims to examine the role of weight gain in adipose tissue immune cell influx and
development of obesity related cardiometabolic disorders. Adipose tissue-mediated chronic
systemic inflammation is implicated in the development of cardiometabolic disorders in
obesity. Therefore, resolution of adipose tissue inflammation may be key to ameliorating
obesity-associated dyslipidemia, insulin-resistance, and cardiovascular disease.
Proinflammatory cytokines contribute to the initial influx of immune cells into adipose
tissue during weight gain. However, mechanisms regulating these cytokines in the adipose
tissue milieu and the effects of weight gain on adipose tissue are not completely understood.
The study proposes to investigate the molecular events contributing to increased infiltration
of macrophages and T-cells into adipose tissue during weight gain. The central hypothesis is
that in lean subjects (with low body fat mass), healthy fat gain which is associated with
decreased expression of proinflammatory cytokines. However, in obesity (high body fat mass),
adipose tissue is altered, which permits increased expression of inflammatory cytokines and
further fat gain results in influx of immune cells. To test the hypothesis, adipose tissue
from well characterized lean (control, with low body fat) and obese individuals (with high
body fat) at baseline and after a modest 5% weight gain will be used. Adipose tissue samples
after subsequent weight loss will also be examined.
For this study, obesity will be defined by body composition rather than body mass index
(BMI), as several studies have shown that BMI does not adequately define obesity and several
individuals with normal BMI may indeed have high body fat mass. Individuals with body fat
content ≤25% for men, & <35% for women) will be considered lean and individuals with body fat
content >25% for men, ≥35% for women will be considered obese.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |